Celebration for patients after India’s landmark ruling against Swiss drug giant Novartis means millions can afford generic medicines

 

Delhi

For Sourabh Ghosh, it was nothing less than a matter of life or death.

Diagnosed with leukaemia more than a decade ago, the Delhi student was able to obtain a life-saving but expensive Swiss-produced medicine, firstly through a donation scheme and later through his medical insurance while studying in the US.

But when he returned to India in 2008, he was told he would have to pay for the drug. His salvation came in the form of a copy-cat medicine manufactured by an Indian company at a fraction of the cost.

“It would have been a disaster if this alternative was not available. If I stopped taking medicine the leukaemia would have relapsed,” said Mr Ghosh, now a professor at the Indian Institute of Technology. “If you don’t treat it, it becomes aggressive. The patient will die after six to eight months.”

Mr Ghosh, 40, was on Monday among millions of people around the world celebrating a decision by India’s highest court not to grant a patent to a drugs manufacturer in a case campaigners say will help safeguard the ability of patients to afford life-saving medicine.

In a landmark case, the supreme court rejected a patent application by Novartis AG for a drug it claims was an updated anti-leukaemia treatment. Activists said the judgement would protect India’s £17bn generic drug industry, which makes cheaper imitations of life-saving medicine.

The dispute involving Novartis, a Swiss-based multi-national pharmaceutical company, dated back seven years and centred on its attempt to seek a patent for its anti-cancer drug Glivec. Glivec, which has been celebrated as a breakthrough in treating forms of blood cancer, costs £1,700 a month in its branded form while the generic version is available in India from £115.

The company claimed the drug was a new product while activists said it was merely a slightly modified version of an earlier product whose patent had expired.

Activists said today’s ruling means other drug companies will also be prevented from obtaining patents on updated version of exiting drugs, a practise known as “ever-greening”. They said the impact will be felt around the world.

Pratibha Singh, a lawyer for generic drug producer Cipla, part of an industry that is expected to be worth £46bn by 2010, told the AFP that the “ruling will have implications not just for India but also for other Asian, African and Latin American countries”.

She added: “The ruling also makes it clear you cannot patent a drug by just making some minor modifications — the key Section 3d of the patent law has been upheld by the court.”

Mr Ghosh started taking Glivec after he was diagnosed with chronic myeloid leukaemia, a cancer of the white blood cells, in 2000.

While he was for some years able to access the drug through a donation scheme, since 2008 Mr Ghosh has been taking a generic version of the medicine. He will have to take it for the rest of his life. “I am doing perfectly well. I play sport, I swim,” said Mr Ghosh.

India’s generic drugs industry supplies around one-fifth of the world’s imitation drugs. It assumed this position because until 2005 it did not issue patents on drugs and only did so to comply with World Trade Organisation rules.

Novartis and other drug manufacturers argue that patents are required to protect products that have required large sums in development research and testing.

“We brought this case because we strongly believe patents safeguard innovation and encourage medical progress, particularly for unmet medical needs,” said Ranjit Shahani, of Novartis India Limited. “This ruling is a setback for patients that will hinder medical progress for diseases without effective treatment options.”

Novartis’ application for a fresh patent in India was turned down by the country’s patent office in 2005. It then filed an appeal, saying that the new product could be more easily absorbed and therefore qualified as a new product. That appeal was in turn rejected so the company turned to the supreme court.

Kiran Hukku of the Cancer Patients Aid Association, said over the last three years it had helped provide generic drugs to around 5,000 cancer patients who were still alive as a result of the medicine. “So many lives will be saved as a result [of today’s ruling],” she said.

Vikas and Preeti Ahuja were also celebrating Monday’s decision. Both have HIV and need to take two daily treatments of lamivudine, nevirapine and zidovudine. They receive their drugs from the Indian government, which purchases them from a generic manufacturer, again at a fraction of the normal cost.

Mr Ahuja, who was infected via a blood transfusion when he was a student and who is chairman of the Delhi Network of Positive People, said he regularly sent packages of such generic drugs to places such as China, Vietnam and even East Timor, where they are not available.

He said: “I would have been dead a long time ago without the generic treatment. If this decision had gone the other way it would have been a disaster, and a prolonged disaster. It would have affected future generations.”

Arts and Entertainment
books
Voices
Caustic she may be, but Joan Rivers is a feminist hero, whether she likes it or not
voicesShe's an inspiration, whether she likes it or not, says Ellen E Jones
Arts and Entertainment
The Doctor and the Dalek meet
tvReview: Doctor Who Into the Dalek more than compensated for last week's nonsensical offering
Sport
Diego Costa
footballEverton 3 Chelsea 6: Diego Costa double has manager purring
PROMOTED VIDEO
Have you tried new the Independent Digital Edition apps?
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
Life and Style
3D printed bump keys can access almost any lock
techSoftware needs photo of lock and not much more
Arts and Entertainment
The 'three chords and the truth gal' performing at the Cornbury Music Festival, Oxford, earlier this summer
music... so how did she become country music's hottest new star?
Life and Style
The spy mistress-general: A lecturer in nutritional therapy in her modern life, Heather Rosa favours a Byzantine look topped off with a squid and a schooner
fashionEurope's biggest steampunk convention heads to Lincoln
News
Dr Alice Roberts in front of a
peopleAlice Roberts talks about her new book on evolution - and why her early TV work drew flak from (mostly male) colleagues
News
i100
Arts and Entertainment
Star turns: Montacute House
tv
News
i100Steve Carell selling chicken, Tina Fey selling saving accounts and Steve Colbert selling, um...
Arts and Entertainment
Unsettling perspective: Iraq gave Turner a subject and a voice (stock photo)
booksBrian Turner's new book goes back to the bloody battles he fought in Iraq
News
The Digicub app, for young fans
advertisingNSPCC 'extremely concerned'
News
i100
Arts and Entertainment
Some of the key words and phrases to remember
booksA user's guide to weasel words
Independent
Travel Shop
the manor
Up to 70% off luxury travel
on city breaks Find out more
santorini
Up to 70% off luxury travel
on chic beach resorts Find out more
sardina foodie
Up to 70% off luxury travel
on country retreats Find out more
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Senior Data Scientist (Data Mining, RSPSS, R, AI, CPLEX, SQL)

£60000 - £70000 per annum + Benefits + Bonus: Harrington Starr: Senior Data Sc...

Law Costs

Highly Attractive Salary: Austen Lloyd: BRISTOL - This is a very unusual law c...

Junior VB.NET Application Developer (ASP.NET, SQL, Graduate)

£28000 - £30000 per annum + Benefits + Bonus: Harrington Starr: Junior VB.NET ...

C# .NET Web Developer (ASP.NET, JavaScript, jQuery, XML, XLST)

£40000 - £50000 per annum + Benefits + Bonus: Harrington Starr: C# .NET Web De...

Day In a Page

The other Mugabe who is lining up for the Zimbabwean presidency

The other Mugabe who is lining up for the Zimbabwean presidency

Wife of President Robert Mugabe appears to have her sights set on succeeding her husband
The model of a gadget launch: Cultivate an atmosphere of mystery and excitement to sell stuff people didn't realise they needed

The model for a gadget launch

Cultivate an atmosphere of mystery and excitement to sell stuff people didn't realise they needed
Alice Roberts: She's done pretty well, for a boffin without a beard

She's done pretty well, for a boffin without a beard

Alice Roberts talks about her new book on evolution - and why her early TV work drew flak from (mostly male) colleagues
Get well soon, Joan Rivers - an inspiration, whether she likes it or not

Get well soon, Joan Rivers

She is awful. But she's also wonderful, not in spite of but because of the fact she's forever saying appalling things, argues Ellen E Jones
Doctor Who Into the Dalek review: A classic sci-fi adventure with all the spectacle of a blockbuster

A fresh take on an old foe

Doctor Who Into the Dalek more than compensated for last week's nonsensical offering
Fashion walks away from the celebrity runway show

Fashion walks away from the celebrity runway show

As the collections start, fashion editor Alexander Fury finds video and the internet are proving more attractive
Meet the stars of TV's Wolf Hall... and it's not the cast of the Tudor trilogy

Meet the stars of TV's Wolf Hall...

... and it's not the cast of the Tudor trilogy
Weekend at the Asylum: Europe's biggest steampunk convention heads to Lincoln

Europe's biggest steampunk convention

Jake Wallis Simons discovers how Victorian ray guns and the martial art of biscuit dunking are precisely what the 21st century needs
Don't swallow the tripe – a user's guide to weasel words

Don't swallow the tripe – a user's guide to weasel words

Lying is dangerous and unnecessary. A new book explains the strategies needed to avoid it. John Rentoul on the art of 'uncommunication'
Daddy, who was Richard Attenborough? Was the beloved thespian the last of the cross-generation stars?

Daddy, who was Richard Attenborough?

The atomisation of culture means that few of those we regard as stars are universally loved any more, says DJ Taylor
She's dark, sarcastic, and bashes life in Nowheresville ... so how did Kacey Musgraves become country music's hottest new star?

Kacey Musgraves: Nashville's hottest new star

The singer has two Grammys for her first album under her belt and her celebrity fans include Willie Nelson, Ryan Adams and Katy Perry
American soldier-poet Brian Turner reveals the enduring turmoil that inspired his memoir

Soldier-poet Brian Turner on his new memoir

James Kidd meets the prize-winning writer, whose new memoir takes him back to the bloody battles he fought in Iraq
Aston Villa vs Hull match preview: Villa were not surprised that Ron Vlaar was a World Cup star

Villa were not surprised that Vlaar was a World Cup star

Andi Weimann reveals just how good his Dutch teammate really is
Bill Granger recipes: Our chef ekes out his holiday in Italy with divine, simple salads

Bill Granger's simple Italian salads

Our chef presents his own version of Italian dishes, taking in the flavours and produce that inspired him while he was in the country
The Last Word: Tumbleweed through deserted stands and suites at Wembley

The Last Word: Tumbleweed through deserted stands and suites at Wembley

If supporters begin to close bank accounts, switch broadband suppliers or shun satellite sales, their voices will be heard. It’s time for revolution